Patents by Inventor Libo Wu
Libo Wu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20220252457Abstract: A passive infrared (PIR) sensor system, includes a PIR sensor configured to produce an output signal in response to receiving infrared (IR) radiation, an electronic shutter positionable in a field of view (FOV) of the PIR sensor, wherein the electronic shutter includes a liquid crystal (LC) material, wherein the electronic shutter includes a first state providing a first transmissivity of IR radiation through the electronic shutter and a second state providing a second transmissivity of IR radiation through the electronic shutter that is less than the first transmissivity, and a shutter actuator configured to apply an actuation signal to the electronic shutter to actuate the electronic shutter between the first state and the second state.Type: ApplicationFiled: June 19, 2020Publication date: August 11, 2022Applicant: The Texas A&M University SystemInventors: Ya Wang, Libo Wu, Zhangjie Chen
-
Patent number: 10514132Abstract: A lighting apparatus includes a housing, an electroluminescent quantum dots (QD) unit as a light source, and an electrical component for providing electrical energy to the electroluminescent QD unit. The housing may be in the form of an incandescent bulb, a halogen bulb, a fluorescent tube or a panel. The electroluminescent QD unit includes a plurality of QDs printed on an insulating substrate. The substrate may be flexible so that the electroluminescent QD unit may be bent or curved to conform to the shape of an incandescent bulb, fluorescent tube or panel or a halogen filament so as to mimic these traditional light sources. Methods for retrofitting traditional or LED light fixtures with a lighting apparatus including an electroluminescent quantum dots (QD) unit as a light source are also described.Type: GrantFiled: August 24, 2016Date of Patent: December 24, 2019Assignee: SABIC Global Technologies B.V.Inventors: Yingjun Cheng, Andries Jakobus Petrus Van Zyl, Libo Wu
-
Patent number: 10492101Abstract: Embodiments of the present invention provide a method for enhancing a processing capability of a base station, a baseband device, a base station, and a system. The method includes: receiving, by a base station, data of a terminal; performing control plane protocol processing on the terminal by using a first BBP, and performing all or part of data transmission protocol processing on the data of the terminal by using a second BBP; and sending processed data of the terminal. In this way, another BBP shares all or part of data transmission protocol processing for a terminal that accesses a BBP, to enhance a processing capability of the base station on the whole, thereby implementing inter-board load balancing.Type: GrantFiled: June 9, 2017Date of Patent: November 26, 2019Assignee: Huawei Technologies Co., Ltd.Inventor: Libo Wu
-
Patent number: 10317019Abstract: An illumination device including an LED mounting platform (2) having a peripheral region (2a) and a relatively inner region (2b); at least one warm white LED (3) and at least one cool white LED (4) mounted adjacent the peripheral region (2a) of the LED mounting platform (2), and, at least one RGB LED (5) mounted adjacent the relatively inner region (2b) of the LED mounting platform (2); a diffusion cover (10) configured to allow light emitted from the at least one warm white LED (3), the at least one cool white LED (4), and the at least one RGB LED (5) to pass therethrough; and wherein at least one light emission characteristic of light emitted from the at least one warm white LED (3), the at least one cool white LED (4), and/or the at least one RGB LED (5) is configured to be selectably varied in response to an input control signal so as to produce a plurality of lighting modes.Type: GrantFiled: August 22, 2014Date of Patent: June 11, 2019Assignee: TAOLIGHT COMPANY LIMITEDInventors: Huahui Li, Jiezhao Wang, Yingying Zhao, Bertrand Delalande, Bruno Couthouis, Jean-Eudes Leroy, Libo Wu
-
Publication number: 20190036082Abstract: An integrated substrate includes a substrate having a first surface and a second surface, and a light extraction layer disposed on the first surface of the substrate. The light extraction layer includes a polyimide having a glass transition temperature of greater than 200 to 350° C., and a plurality of nanoparticles, and the light extraction layer has a refractive index of 1.7 to 2.0. A method of manufacturing the integrated substrate is also disclosed, where the method includes applying the light extraction layer on the first surface of the substrate. An optical device including the integrated substrate is also described.Type: ApplicationFiled: January 27, 2017Publication date: January 31, 2019Inventors: Yingjun Cheng, Libo Wu, Andries Jakobus Petrus van Zyl, Wei Feng
-
Patent number: 10129943Abstract: A dimmable LED module configured for electrical connection with an AC mains power supply via a switch (9), the dimmable lighting module including a plurality of activatable LED light sources configured for emitting a corresponding lighting characteristic when activated, and, a control unit (4) configured for selectably activating at least one of the plurality of LED light sources in response to a control signal generated by a predetermined switching operation of the switch (9) that is received by the control unit (4) such that a plurality of lighting modes are able to be selectably output from the dimmable LED module corresponding to the at least one of the plurality of LED light sources that are selectably activated by the control unit (4), the plurality of lighting modes being indicative of a resulting lighting characteristic emitted by the at least one of the plurality of selectably activated LED light sources corresponding to the lighting modes, wherein the plurality of lighting modes include at least a fType: GrantFiled: October 28, 2014Date of Patent: November 13, 2018Assignee: TAOLIGHT COMPANY LIMITEDInventors: Huahui Li, Bertrand Delalande, Jerome Leroy, Libo Wu
-
Publication number: 20180245742Abstract: A lighting apparatus includes a housing, an electroluminescent quantum dots (QD) unit as a light source, and an electrical component for providing electrical energy to the electroluminescent QD unit. The housing may be in the form of an incandescent bulb, a halogen bulb, a fluorescent tube or a panel. The electroluminescent QD unit includes a plurality of QDs printed on an insulating substrate. The substrate may be flexible so that the electroluminescent QD unit may be bent or curved to conform to the shape of an incandescent bulb, fluorescent tube or panel or a halogen filament so as to mimic these traditional light sources. Methods for retrofitting traditional or LED light fixtures with a lighting apparatus including an electroluminescent quantum dots (QD) unit as a light source are also described.Type: ApplicationFiled: August 24, 2016Publication date: August 30, 2018Inventors: Yingjun CHENG, Andries Jakobus Petrus VAN ZYL, Libo WU
-
Publication number: 20170280356Abstract: Embodiments of the present invention provide a method for enhancing a processing capability of a base station, a baseband device, a base station, and a system. The method includes: receiving, by a base station, data of a terminal; performing control plane protocol processing on the terminal by using a first BBP, and performing all or part of data transmission protocol processing on the data of the terminal by using a second BBP; and sending processed data of the terminal. In this way, another BBP shares all or part of data transmission protocol processing for a terminal that accesses a BBP, to enhance a processing capability of the base station on the whole, thereby implementing inter-board load balancing.Type: ApplicationFiled: June 9, 2017Publication date: September 28, 2017Inventor: Libo Wu
-
Publication number: 20170245336Abstract: A dimmable LED module configured for electrical connection with an AC mains power supply via a switch (9), the dimmable lighting module including a plurality of activatable LED light sources configured for emitting a corresponding lighting characteristic when activated, and, a control unit (4) configured for selectably activating at least one of the plurality of LED light sources in response to a control signal generated by a predetermined switching operation of the switch (9) that is received by the control unit (4) such that a plurality of lighting modes are able to be selectably output from the dimmable LED module corresponding to the at least one of the plurality of LED light sources that are selectably activated by the control unit (4), the plurality of lighting modes being indicative of a resulting lighting characteristic emitted by the at least one of the plurality of selectably activated LED light sources corresponding to the lighting modes, wherein the plurality of lighting modes include at least a fType: ApplicationFiled: October 28, 2014Publication date: August 24, 2017Inventors: Huahui Li, Bertrand Delalande, Jerome Leroy, Libo Wu
-
Publication number: 20170241601Abstract: An illumination device including an LED mounting platform (2) having a peripheral region (2a) and a relatively inner region (2b); at least one warm white LED (3) and at least one cool white LED (4) mounted adjacent the peripheral region (2a) of the LED mounting platform (2), and, at least one RGB LED (5) mounted adjacent the relatively inner region (2b) of the LED mounting platform (2); a diffusion cover (10) configured to allow light emitted from the at least one warm white LED (3), the at least one cool white LED (4), and the at least one RGB LED (5) to pass therethrough; and wherein at least one light emission characteristic of light emitted from the at least one warm white LED (3), the at least one cool white LED (4), and/or the at least one RGB LED (5) is configured to be selectably varied in response to an input control signal so as to produce a plurality of lighting modes.Type: ApplicationFiled: August 22, 2014Publication date: August 24, 2017Inventors: Huahui Li, Jiezhao Wang, Yingying Zhao, Bertrand Delalande, Bruno Couthouis, Jean-Eudes Leroy, Libo Wu
-
Publication number: 20170231976Abstract: 8?-Hydroxy-Dihydroergotamine (8?-OH DHE) medicinal compounds, compositions, and dosage forms containing such compositions are provided. Also provided herein are methods of treatment, prevention, or amelioration of diseases, conditions or disorders selected from amyotrophic lateral sclerosis (ALS), Parkinson's disease, stress/anxiety, nausea, emesis, aggression, pain, neuropathic pain, sleeplessness, insomnia, restless leg syndrome and depression using the compounds, compositions, dosage forms and administration techniques disclosed herein.Type: ApplicationFiled: May 3, 2017Publication date: August 17, 2017Inventors: Thomas Armer, Shashidhar Kori, Libo Wu
-
Patent number: 9707295Abstract: The present invention provides a solution formulation for inhalation comprising: a liquid phase; an active ingredient containing a carboxylic ester in which the oxygen atom is covalently bound to a quaternary nitrogen-containing heterocycle, dissolved in the liquid phase; and a magnesium or calcium salt, dissolved in the liquid phase. The formulation is particularly suited to pMDIs and nebulizers.Type: GrantFiled: May 3, 2016Date of Patent: July 18, 2017Assignee: Teva Branded Pharmaceutical Products R&D, Inc.Inventors: Mukul Dalvi, Libo Wu
-
Publication number: 20160250197Abstract: Accordingly, the present invention provides a solution formulation for inhalation comprising: a liquid phase; an active ingredient having a functional group which is susceptible to hydrolysis and/or solvolysis, dissolved in the liquid phase; and a magnesium or calcium salt, dissolved in the liquid phase. The formulation is particularly suited to pMDIs and nebulisers.Type: ApplicationFiled: November 21, 2014Publication date: September 1, 2016Applicant: Teva Branded Pharmaceutical Products R&D, Inc.Inventors: Mukul Dalvi, Libo Wu
-
Publication number: 20160243241Abstract: The present invention provides a solution formulation for inhalation comprising: a liquid phase; an active ingredient containing a carboxylic ester in which the oxygen atom is covalently bound to a quaternary nitrogen-containing heterocycle, dissolved in the liquid phase; and a magnesium or calcium salt, dissolved in the liquid phase. The formulation is particularly suited to pMDIs and nebulisers.Type: ApplicationFiled: May 3, 2016Publication date: August 25, 2016Applicant: Teva Branded Pharmaceutical Products R&D, Inc.Inventors: Mukul DALVI, Libo WU
-
Patent number: 9392716Abstract: A driver assembly includes a driver housing and a driver, the driver including at least one first portion and a second portion, the first portion having a lower heat resistance than the second portion, wherein the driver housing includes at least one first cavity for at least partially accommodating the first portion and a second cavity for accommodating the second portion, and a potting material is potted into the first cavity to envelop the first portion.Type: GrantFiled: October 10, 2012Date of Patent: July 12, 2016Assignee: OSRAM GMBHInventors: MingTao Wang, Guoan He, LiBo Wu
-
Patent number: 9364540Abstract: The present invention provides a solution formulation for inhalation comprising: a liquid phase; an active ingredient containing a carboxylic ester in which the oxygen atom is covalently bound to a quaternary nitrogen-containing heterocycle, dissolved in the liquid phase; and a magnesium or calcium salt, dissolved in the liquid phase. The formulation is particularly suited to pMDIs and nebulizers.Type: GrantFiled: February 5, 2015Date of Patent: June 14, 2016Assignee: Teva Branded Pharmaceutical Products R&D, Inc.Inventors: Mukul Dalvi, Libo Wu
-
Publication number: 20150306096Abstract: 8?-Hydroxy-Dihydroergotamine (8?-OH DHE) medicinal compounds, compositions, and dosage forms containing such compositions are provided. Also provided herein are methods of treatment, prevention, or amelioration of diseases, conditions or disorders selected from amyotrophic lateral sclerosis (ALS), Parkinson's disease, stress/anxiety, nausea, emesis, aggression, pain, neuropathic pain, sleeplessness, insomnia, restless leg syndrome and depression using the compounds, compositions, dosage forms and administration techniques disclosed herein.Type: ApplicationFiled: April 29, 2015Publication date: October 29, 2015Inventors: Thomas Armer, Shashidhar Kori, Libo Wu
-
Patent number: 9152482Abstract: The present invention provides a multi-core processor system, including: multiple central processor units and multiple groups of level-one hardware message queues. Each central processor unit is separately connected to a group of level-one hardware message queues and is configured to process messages in the level-one hardware message queues. Each group of level-one hardware message queues includes multiple level-one hardware message queues. Moreover, in each group of level-one hardware message queues, a level-one hardware message queue having a higher priority is scheduled preferentially, and level-one hardware message queues having the same priority are scheduled in a round-robin manner according to round robin scheduling weights. Through the multi-core processor system provided in the present invention, the efficiency and performance of the multi-core processor system are improved.Type: GrantFiled: April 28, 2014Date of Patent: October 6, 2015Assignee: Huawei Technologies Co., Ltd.Inventors: Weiguo Zhang, Libo Wu
-
Publication number: 20150265531Abstract: Described here are compositions and methods for the treatment of respiratory conditions using glucocorticosteroids delivered by a next generation nebulizer. The methods administer a therapeutic dose with nebulization time of 2 minutes or less. The faster nebulization time improves patient compliance.Type: ApplicationFiled: June 2, 2015Publication date: September 24, 2015Inventors: Libo Wu, Wiwik Watanabe
-
Publication number: 20150238487Abstract: Provided herein are 8?-Hydroxy-2-CF3-dihydroergotamine (8?OH-2-CF3-DHE) compounds, compositions, and dosage forms containing such compositions. Also provided herein are methods of treatment, prevention, or amelioration of a variety of medical disorders such as, for example, migraine using the compounds and compositions disclosed herein. In still other embodiments, provided herein are methods of agonizing receptors such as, for example, the 5-HT1D and/or the 5-HT1B receptor, without agonizing the 5-HT2B receptor using the compounds and compositions disclosed herein. In still other embodiments, provided herein are methods of antagonizing or inhibiting activity at receptors such as, for example, the adrenergic alpha2A and/or the alpha2B receptors using the compounds and compositions disclosed herein.Type: ApplicationFiled: April 28, 2015Publication date: August 27, 2015Inventors: Thomas Armer, Shashidhar Kori, Libo Wu